Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate

Chronic inflammation is a risk factor for the onset of cancer and the regular use of aspirin reduces the risk of cancer development. Here we showed that therapeutic dosages of aspirin counteract the pro-tumorigenic effects of the inflammatory cytokine interleukin(IL)-6 in cancer and non-cancer cell...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Brighenti, Elisa, Giannone, Ferdinando Antonino, Fornari, Francesca, Onofrillo, Carmine, Govoni, Marzia, Montanaro, Lorenzo, Treré, Davide, Derenzini, Massimo
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5325359/
https://ncbi.nlm.nih.gov/pubmed/27557515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11441
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados